Solesence, Inc.
SLSN
Positions held
Your positionsSLSN isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $59.08M | Enterprise value | $80.73M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 4.50 | Beta | 1.38 | Dividend yield | 0.00% |
| Revenue growth | -24.7% | Earnings growth | — | Gross margin | 25.0% | Operating margin | 0.8% |
| Profit margin | -5.3% | ROE | -18.6% | ROA | -2.4% | Debt / equity | 1.73 |
| Current ratio | 0.97 | Free cash flow | $3.19M | Analyst recommendation | none | Mean target | — |
| 52w high | $4.00 | 52w low | $0.61 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $15.3M | $13.0M | $12.5M | $14.6M | $20.4M |
| Op margin | 0.8% | -3.9% | 1.5% | -5.4% | 12.2% |
| Net income | -$0.2M | -$0.8M | $0.2M | -$1.1M | $3.2M |
| Gross margin | 31.0% | 25.8% | 27.5% | 23.1% | 31.6% |
| Gross profit | $4.7M | $3.3M | $3.4M | $3.4M | $6.4M |
| Operating income | $0.1M | -$0.5M | $0.2M | -$0.8M | $2.5M |
- Revenue +18% vs prior quarter ($15M vs $13M).
- Gross margin 31% (was 25.8% prior quarter).
- Operating margin expanded to 0.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $62.1M | $52.3M | $37.3M | $37.3M | — |
| Op margin | 2.5% | 9.8% | -9.5% | -6.1% | — |
| Net income | $1.8M | $4.2M | -$4.4M | -$2.6M | — |
| Gross margin | 25.9% | 30.9% | 21.0% | 22.4% | — |
| Gross profit | $16.1M | $16.2M | $7.8M | $8.4M | — |
| Operating income | $1.6M | $5.1M | -$3.5M | -$2.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-25 · SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt
2026-08-20 · Solesence, Inc. Common Stock Q2 2026 Earnings Call Summary
2026-08-20 · Solesence Inc (SLSN) (Q2 2026) Earnings Call Highlights: Strong Order Book Signals Record ...
2026-08-19 · Solesence Posts Breakeven Q2 as Revenue Falls
2026-08-19 · Solésence Reports Second Quarter 2026 Financial Results
2026-08-10 · Solésence Reschedules Second Quarter 2026 Conference Call to August 19
2026-07-28 · Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
2026-07-14 · SLSN Unveils Two Scalp Care Products Using Patented Technology
2026-07-13 · Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
Price (daily)
Full chart · RSI · MACD · patterns